+794.9%
MRNA vs AFRM
-16.7%
+811.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AFRM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.1% | -2.3% | -2.7% |
| 7D | -12.1% | -4.4% | -7.7% | -9.3% |
| 30D | -1.3% | -7.7% | +6.4% | +4.7% |
| 3M | +250.9% | -16.9% | +267.8% | +295.0% |
| 6M | +343.0% | +2.5% | +340.5% | +366.6% |
| YTD | +657.4% | -12.5% | +670.0% | +751.4% |
| 1Y | +794.9% | -11.0% | +805.9% | +946.1% |
| All | +794.9% | -16.7% | +811.6% | +946.1% |
Cumulative growth
Daily Returns
Daily percentage return beside AFRM.
Daily Out/Under-Performance
Portfolio return minus AFRM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AFRM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AFRM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling